Skip to content
FDA with Dr. Harpreet Singh episode artwork

Jun 1, 2021 37 min

FDA with Dr. Harpreet Singh

from Lung Cancer Considered Hosted by IASLC

In this episode of Lung Cancer Considered, Dr. Stephen Liu sits down with guest Dr. Harpreet Singh from the FDA to discuss the agency’s oncology drug approval process. The interview also covers how new drug approvals are handled in other countries

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

FDA with Dr. Harpreet Singh

0:00 37:41

No transcript yet.

Requests help us decide what to transcribe next.

Share this episode

Similar podcasts

Lung Cancer Update for Nurses Dr Neil Love Featuring one-on-one interviews conducted by Dr Neil Love with national lung cancer clinical investigators and oncology nurses, this series provides practicing clinicians including nurses and nurse practitioners with valuable information and current clinical management strategies that can be applied to optimize patient care.

Frequently asked questions

How long is this episode of Lung Cancer Considered?

This episode is 37 minutes long.

When was this Lung Cancer Considered episode published?

This episode was published on June 1, 2021.

Can I download this Lung Cancer Considered episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.